Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryszard Lauterbach

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Evidence-Based Medicine|August 19, 2015
A supplementation of DHA and AA to human milk-fed VLBW infants has no significant cognitive improvement or measurable neuroanatomical effects when evaluated at 8 years of ageRyszard Lauterbach
Ebiomedicine|August 13, 2018
EPA + DHA in Prevention of Early Preterm Birth - Do We Know How to Apply it?Ryszard Lauterbach
Developmental Period Medicine|September 4, 2014
Nasal CPAP (Infant Flow) applied at birth in extremely low birth weight newbornsAgnieszka Nowicka, Ryszard Lauterbach
Developmental Period Medicine|January 14, 2019
Compliance with the RSV immunoprophylaxis dosing schedule in the Polish registry for palivizumab (2008-2014)Róża Borecka, Ryszard Lauterbach
Medycyna Wieku Rozwojowego|May 28, 2009
[Fungal infections in the neonate - diagnosis, treatment and prevention]Dorota Pawlik, Ryszard Lauterbach
Medycyna Wieku Rozwojowego|May 28, 2009
[Enteral nutrition in premature newborn infants with sepsis]Dorota Pawlik, Ryszard Lauterbach
Medycyna Wieku Rozwojowego|May 28, 2009
[Selective surfactant treatment for neonatal respiratory distress syndrome]Dorota Pawlik, Ryszard Lauterbach
Przeglad Lekarski|July 11, 2002
[Retinopathy of prematurity: risk factors analysis]Ewa Ortyl, Ryszard Lauterbach, Maria Starzycka
Medycyna Wieku Rozwojowego|May 8, 2009
[Immunization in preterm infants--current knowledge]Hanna Czajka, Izabela Tarczoń, Ryszard Lauterbach
Developmental Period Medicine|December 13, 2016
Factors related to compliance with palivizumab prophylaxis for respiratory syncytial virus (RSV) infection - data from PolandRóża Borecka, Ryszard Lauterbach, Ewa Helwich
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Evidence-Based Medicine|August 19, 2015
A supplementation of DHA and AA to human milk-fed VLBW infants has no significant cognitive improvement or measurable neuroanatomical effects when evaluated at 8 years of ageRyszard Lauterbach
Ebiomedicine|August 13, 2018
EPA + DHA in Prevention of Early Preterm Birth - Do We Know How to Apply it?Ryszard Lauterbach
Developmental Period Medicine|September 4, 2014
Nasal CPAP (Infant Flow) applied at birth in extremely low birth weight newbornsAgnieszka Nowicka, Ryszard Lauterbach
Developmental Period Medicine|January 14, 2019
Compliance with the RSV immunoprophylaxis dosing schedule in the Polish registry for palivizumab (2008-2014)Róża Borecka, Ryszard Lauterbach
Medycyna Wieku Rozwojowego|May 28, 2009
[Fungal infections in the neonate - diagnosis, treatment and prevention]Dorota Pawlik, Ryszard Lauterbach
Medycyna Wieku Rozwojowego|May 28, 2009
[Enteral nutrition in premature newborn infants with sepsis]Dorota Pawlik, Ryszard Lauterbach
Medycyna Wieku Rozwojowego|May 28, 2009
[Selective surfactant treatment for neonatal respiratory distress syndrome]Dorota Pawlik, Ryszard Lauterbach
Przeglad Lekarski|July 11, 2002
[Retinopathy of prematurity: risk factors analysis]Ewa Ortyl, Ryszard Lauterbach, Maria Starzycka
Medycyna Wieku Rozwojowego|May 8, 2009
[Immunization in preterm infants--current knowledge]Hanna Czajka, Izabela Tarczoń, Ryszard Lauterbach
Developmental Period Medicine|December 13, 2016
Factors related to compliance with palivizumab prophylaxis for respiratory syncytial virus (RSV) infection - data from PolandRóża Borecka, Ryszard Lauterbach, Ewa Helwich
Pageof 7